Cardiovascular Research · 2010 · 46 citations · 24 references
MedicineOncologyPharmacologyCardio-oncologyChemotherapyMolecular OncologyAnthracycline CardiotoxicityCancer Therapy-related CardiotoxicityCardiac PharmacotherapyCardiac PhysiologyCardiovascular Molecular PhysiologyAnthracycline-based ChemotherapyAnthracycline-induced CardiomyopathyAnthracycline-induced CardiotoxicityDaunorubicin CardiotoxicityDoxorubicin CardiotoxicityMechanisms Of Cardiac InjurySurvival FactorSurvival Factor Signaling
AIMS: Anthracyclines such as daunorubicin (DNR) and doxorubicin are effective cancer chemotherapeutic agents, but can induce cardiotoxicity. GATA4 has been shown to serve as a survival factor of cardiac muscle cells, and anthracyclines promote apoptosis in part by down-regulating GATA4. The present study investigated the mechanism of anthracycline action to down-regulate GATA4. METHODS AND RESULTS: DNR inhibited the transcriptional activity exhibited by the 250 bp conserved region immediately upstream from the transcriptional start site of the Gata4 gene. Mapping this region identified that the CCAAT-binding factor/nuclear factor-Y (CBF/NF-Y) binding to the CCAAT box was inhibited by DNR in HL-1 cardiac muscle cells and in perfused isolated mouse hearts. The DNR action on the Gata4 promoter was found to be dependent on p53, since DNR promoted nuclear binding of p53 to CBF/NF-Y and pifithrin-α (a p53 inhibitor) attenuated DNR down-regulation of GATA4. CONCLUSION: Anthracycline down-regulation of GATA4 is mediated by the inhibition of Gata4 gene transcription via a novel mechanism that involves the p53-dependent inhibition of CBF/NF-Y binding to the CCAAT box within the Gata4 promoter.
24
William C. Claycomb, Nicholas A. Lanson, Beverly S. Stallworth et al. · Proceedings of the National Academy of Sciences · 1998 · 1.5K citations
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Pavel G. Komarov, Elena A. Komarova, Roman V. Kondratov et al. · Science · 1999 · 1.3K citations
Medicine, Oncology, Pharmacology +17
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Masanori Sano, Tohru Minamino, Haruhiro Toko et al. · Nature · 2007 · 896 citations
Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
Olli Arola, Antti Saraste, Kari Pulkki et al. · PubMed · 2000 · 490 citations
Medicine, Pharmacology, Toxicology +14